Saturday 7 November 2026 Export ANVS’s income statement to Excel — free account

Annovis Bio, Inc.

ANVS Healthcare Biotechnology

EPS: −25.0%
Free cash flow: −329.2%

Quarter to June 2026, against a year earlier

Insider buying

0.82 0.15 +22.39%

Follow ANVS

Alert me

Market cap: $28.6M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(246.14%)	(220.61%)	(301.13%)	(703.68%)
ROA Full definition →		(157.74%)	(164.85%)	(190.43%)	(227.74%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(184.94%)	(165.39%)	(1,185.13%)	(315.88%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(1.27)	(1.25)	(0.95)	(1.16)
Free Cash Flow Full definition →		(24.98)	(25.62)	(26.53)	(43.34)
Other line items
Cash ROIC Full definition →		(87.82%)	(70.42%)	(152.97%)	(299.43%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		1.00	0.89	0.65	0.88
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.27)	(1.25)	(0.95)	(1.16)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates